Ep 304 - J&J MedTech's Polyphonic Lead Explains Why Surgical Intelligence Is the Next Big Shift in the OR

Hey, everyone.

Thompson Lemme here.

Welcome back to the Device Talks weekly podcast.

Great show coming your way.

It's going to be very Chris Newmarker heavy.

Chris Newmarker and I kick things off with our talk of the Newmarkers, Newsmakers, the Top 5 Stories from MassDevice.

We'll also delve a little bit into our experiences, more Chris's experience in DC on the morning of 9-11 in 2001.

Of course, coming up on the 25th, or we're here at the 25th anniversary, uh, as we recorded this episode's, uh, newsmakers on, uh, the morning, Friday morning of September 11th.

So, uh, as I said in our conversation, uh, to those folks who had a more direct, uh, a more direct impact from 9-11 than we did, uh, hope you found some, some peace and, and fond memories, uh, on this, uh, this day.

So, uh, Later on, though, Chris Neutemacher will talk with our main guest.

He's leading our keynote conversation as well.

Chris spoke with Shan Jigatheswaran.

He is the global president of Polyphonic at Johnson & Johnson MedTech.

Johnson & Johnson MedTech, of course, enjoying the approval of Atava a little earlier this year.

In this conversation, Chris and Shan will talk about how surgical intelligence is really the next evolution in digital surgery.

I mean, the tech is here.

But there's a lot of data that needs to be accessed.

So there's a lot of complicated next steps for everyone in the surgical robotics space.

And Johnson & Johnson MedTech has an interesting story with Polyphonic that Chris and Shan will explore.

Hey, everyone.

Thompson Lemme here.

Welcome back to the Device Talks weekly podcast.

Great show coming your way.

It's going to be very Chris Newmarker heavy.

Chris Newmarker and I kick things off with our talk of the Newmarkers, Newsmakers, the Top 5 Stories from MassDevice.

We'll also delve a little bit into our experiences, more Chris's experience in DC on the morning of 9-11 in 2001.

Of course, coming up on the 25th, or we're here at the 25th anniversary, uh, as we recorded this episode's, uh, newsmakers on, uh, the morning, Friday morning of September 11th.

So, uh, as I said in our conversation, uh, to those folks who had a more direct, uh, a more direct impact from 9-11 than we did, uh, hope you found some, some peace and, and fond memories, uh, on this, uh, this day.

So, uh, Later on, though, Chris Neutemacher will talk with our main guest.

He's leading our keynote conversation as well.

Chris spoke with Shan Jigatheswaran.

He is the global president of Polyphonic at Johnson & Johnson MedTech.

Johnson & Johnson MedTech, of course, enjoying the approval of Atava a little earlier this year.

In this conversation, Chris and Shan will talk about how surgical intelligence is really the next evolution in digital surgery.

I mean, the tech is here.

But there's a lot of data that needs to be accessed.

So there's a lot of complicated next steps for everyone in the surgical robotics space.

And Johnson & Johnson MedTech has an interesting story with Polyphonic that Chris and Shan will explore.